others

Latest

Characterisation of CYP2B6 and CYP2A6 pharmacogenetic variation in sub-Saharan African populations
A cross-sectional study of the relationship between CYP2D6 and CYP2C19 variations and depression symptoms, for women taking SSRIs during pregnancy
A pharmacogenomic investigation of the cardiac safety profile of ondansetron in children and pregnant women
Characterization of CYP2D6 Pharmacogenetic Variation in Sub-Saharan African Populations
Patient-specific genetic factors predict treatment failure in sofosbuvir-treated patients with chronic hepatitis C
Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatment
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study
The extent and impact of variation in ADME genes in sub-Saharan African populations
Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicity
Frequency of the loss of CAA interruption in the HTT CAG tract and implications for Huntington disease in the reduced penetrance range
Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease
SJS/TEN 2019: from science to translation
Analyses of adverse drug reactions--nationwide active surveillance network: Canadian pharmacogenomics network for drug safety database
Glutaminase deficiency caused by short tandem repeat expansion in GLS
Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease
Outcome definition influences the relationship between genetic polymorphisms of ERCC1, ERCC2, SLC22A2 and cisplatin nephrotoxicity in adult testicular cancer patients
Pharmacogenomics of vincristine-induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes
Common variation near IRF6 is associated with IFN-$β$-induced liver injury in multiple sclerosis
Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer PatientsThe Role of ACYP2 and WFS1 in Cisplatin-Induced Ototoxicity
Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients
The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population
Association between SLC16A5 genetic variation and cisplatin-induced ototoxic effects in adult patients with testicular cancer
hackseq: Catalyzing collaboration between biological and computational scientists via hackathon
The targetable A1 Huntington disease haplotype has distinct Amerindian and European origins in Latin America
Case-control studies are not familial studies
Nuclear receptor NR1H3 in familial multiple sclerosis
The identification of novel genetic variants associated with antipsychotic treatment response outcomes in first-episode schizophrenia patients
Characterization of the genetic variation present in CYP3A4 in three South African populations
Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study